What is the current Price Target for the PDS Biotechnology Corp. stock?

The average PDS Biotechnology Corp. target price is $12.38. This is 809.93% higher than the current stock price. The highest price target is 1,444.12%, the lowest is 230.88%. 4 Analysts have issued a price target PDS Biotechnology Corp. 2026 .

How high will the PDS Biotechnology Corp. stock rise?

No reliable answer can be given as to how high the PDS Biotechnology Corp. stock will rise. The performance of stocks, including the PDS Biotechnology Corp. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the PDS Biotechnology Corp. stock today?

The performance of PDS Biotechnology Corp. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the PDS Biotechnology Corp. stock fall?

The decline in PDS Biotechnology Corp. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

PDS Biotechnology Corp. Forecast, price target & analysts

$1.33

2.21% today

Nasdaq, Feb 28, 08:45 pm CET

ISIN

US70465T1079

Symbol

PDSB

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

PDS Biotechnology Corp. Target price 2025 - Analyst rating & recommendation

PDS Biotechnology Corp. Classifications & Recommendation:

Buy

100%

PDS Biotechnology Corp. Price Target

Target Price	$12.38
Price	$1.36
Potential	809.93% register free of charge
Number of Estimates	4

	4 Analysts have issued a price target PDS Biotechnology Corp. 2026 . The average PDS Biotechnology Corp. target price is $12.38. This is 809.93% register free of charge higher than the current stock price. The highest price target is $21.00 1,444.12% register free of charge , the lowest is $4.50 230.88% register free of charge .
	A rating was issued by 4 analysts: 4 Analysts recommend PDS Biotechnology Corp. to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the PDS Biotechnology Corp. stock has an average upside potential 2026 of 809.93% register free of charge . Most analysts recommend the PDS Biotechnology Corp. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '23	2024 Estimates
Earnings Per Share $	-1.39	-1.10
	2.80%	20.86%
P/E		negative

1 Analysts have issued a PDS Biotechnology Corp. forecast for earnings per share. The average PDS Biotechnology Corp. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2023	$-1.39	2.80%
2024	$-1.10 20.86% Unlock
2025	$-1.15 4.55% Unlock
2026	$-1.15 0.00% Unlock

Current	-1.17	63.09%
2024	-1.24 5.98% Unlock
2025	-1.18 4.84% Unlock
2026	-1.18 0.00% Unlock

PDS Biotechnology Corp....

Current PDS Biotechnology Corp. Upgrades & Downgrades Beta

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 24 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Dec 18 2024
B. Riley Securities	Locked ➜ Locked	Locked	Nov 25 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 15 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 24 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 02 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 17 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 24 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Dec 18 2024
Locked B. Riley Securities: Locked ➜ Locked	Nov 25 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 15 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 24 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 02 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 17 2024

Discover more stocks with a high price target

Coinbase Global, Inc. 60.51%

BioNTech SE - ADR 30.07%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now